Patents by Inventor Stella Robertson

Stella Robertson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
    Publication number: 20070149593
    Abstract: The present invention relates to development of efficacious intravitreal pharmaceutical compositions comprising a poorly water soluble agent with anti-angiogenic and/or anti vascular leakage properties in a therapeutically effective amount and a co-solvent in a suitable amount to treat or prevent diseases due to ocular neovascularization and enhanced vascular permeability. Other aspects of the invention details the development of efficacious compositions for the treatment of the said diseases via periocular, topical and oral administration.
    Type: Application
    Filed: December 19, 2006
    Publication date: June 28, 2007
    Applicant: Alcon, Inc.
    Inventors: Malay Ghosh, Wesley Han, Way-Yu Lin, David Bingaman, Stella Robertson
  • Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration
    Publication number: 20060166956
    Abstract: The present invention is directed to the use of anercortave acetate or the alcohol thereof for the protection of visual acuity in patients with age related macular degeneration.
    Type: Application
    Filed: June 26, 2003
    Publication date: July 27, 2006
    Inventors: Janice Jerdan, Patricia Zilliox, Stella Robertson
  • Use of steroids to treat ocular disorders
    Publication number: 20060154910
    Abstract: Methods and compositions for treating retinal edema and NPDR are disclosed.
    Type: Application
    Filed: February 4, 2004
    Publication date: July 13, 2006
    Inventors: David Bingaman, Abbot Clark, Rajni Jani, Stella Robertson
  • Formulations of glucocorticoids to treat pathologic ocular angiogenesis
    Publication number: 20060074061
    Abstract: Formulations of glucocorticoids alone and in combination with anecortave acetate are useful for preventing and treating pathologic ocular angiogenesis and associated edema
    Type: Application
    Filed: February 5, 2004
    Publication date: April 6, 2006
    Inventors: David Bingaman, Abbot Clark, Rajni Jani, Stella Robertson